HUMAHumacyte, Inc.同业对比
Humacyte, Inc. 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUMA本股 | $122M#8 | — | 3.9x#11 | 59.7x#8 | — | 72.5%#3 | -5306.0%#9 | -130.6%#11 | — | — | -72.4%#5 | — |
| ACOG | $180M#1 | — | 3.4x#10 | 17.6x#6 | — | -39.8%#11 | -221.7%#4 | -39.0%#6 | — | — | 44.0%#1 | — |
| IVVD | $172M#2 | — | 1.0x#5 | 3.2x#5 | 110.5%#1 | 69.1%#4 | -104.0%#2 | -29.0%#4 | — | — | — | — |
| LIMN | $169M#3 | — | 563.0x#12 | — | — | -187.8%#14 | — | -3395.2%#12 | -170.3%#2 | — | — | — |
| STRO | $157M#4 | — | — | 1.5x#2 | 65.2%#2 | 15.9%#6 | -154.5%#3 | — | — | — | — | — |
| TARA | $144M#5 | — | 0.9x#4 | 48.7x#7 | — | -28.7%#9 | -2189.6%#7 | -35.6%#5 | — | — | — | — |
| CMPX | $138M#6 | — | 0.8x#3 | — | -100.0%#5 | -34.7%#10 | — | -40.0%#7 | — | — | -79.5%#7 | — |
| CHRS | $124M#7 | — | 2.0x#8 | 3.0x#4 | 59.8%#3 | 489.4%#1 | -429.5%#6 | 276.2%#3 | -351.2%#3 | — | -49.3%#2 | — |
| ARMP | $114M#9 | — | — | — | — | -818.8%#15 | — | — | — | — | — | 0.1%#1 |
| VYGR | $113M#10 | — | 0.7x#2 | 2.8x#3 | -49.5%#4 | -84.2%#12 | -326.6%#5 | -77.6%#10 | — | — | -59.9%#3 | — |
| OTLK | $112M#11 | — | — | 79.3x#9 | — | 17.2%#5 | -4744.3%#8 | — | -12.8%#1 | — | -64.7%#4 | — |
| AVXL | $112M#12 | — | 1.0x#6 | — | — | -7.8%#8 | — | -41.2%#8 | — | — | -84.4%#9 | — |
| ENGN | $109M#13 | 0.6x#1 | 0.5x#1 | — | — | -112.7%#13 | — | -50.9%#9 | — | — | -76.5%#6 | — |
| NMRA | $108M#14 | — | 2.4x#9 | — | — | -2.8%#7 | — | 532.2%#2 | -594.0%#4 | — | -80.8%#8 | — |
| BDTX | $104M#15 | — | 1.1x#7 | 1.5x#1 | — | 132.1%#2 | 17.9%#1 | 23276.9%#1 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议